Tech Company Financing Transactions

Magellan Biosciences Funding Round

Magellan Biosciences closed a $50 million investment round on 11/28/2006. Investors included Abingworth, Amidzad Partners and Boston Community Venture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

101 Billerica Ave. Building 4
North Billerica, MA 01862
USA

Phone

(978) 856-2345

Website

www.magellanbio.com

Email Address

[email protected]

Overview

Magellan's innovative products include rapid point-of-care systems to screen children and adults for lead poisoning; microbiology products for blood culture and susceptibility testing that help in the global effort to prevent MRSA and other drug-resistant infections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Amy Winslow

        

Chief Operating Officer

Hossein Maleknia

        

VP - Finance

Janine LeBlanc

        

VP - Sales

Jennifer Zonderman

        

Browse more venture capital transactions:

Prev: 11/28/2006: Tangoe venture capital transaction
Next: 11/28/2006: Serene Medical venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary